KEGG   DRUG: Abacavir sulfate and lamivudine
Entry
D08775            Mixture   Drug                                   

Name
Abacavir sulfate and lamivudine;
Epzicom (TN)
Product
  Generic
Component
Abacavir sulfate [DR:D00891], Lamivudine [DR:D00353]
Remark
Therapeutic category: 6250
ATC code: J05AR02
Product: D08775<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 reverse transcriptase [KO:K24802]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR02 Lamivudine and abacavir
      D08775  Abacavir sulfate and lamivudine <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Abacavir Sulfate/ Lamivudine
    D08775  Abacavir sulfate and lamivudine
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D08775  Abacavir sulfate and lamivudine
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D08775  Abacavir sulfate and lamivudine <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D08775
Other DBs
PubChem: 96025458

» Japanese version   » Back

DBGET integrated database retrieval system